{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:35:00Z","timestamp":1789756500484,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.autrev.2006.04.001","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T11:12:54Z","timestamp":1147000374000},"page":"306-311","source":"Crossref","is-referenced-by-count":27,"title":["Animal models for autoimmune hepatitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Urs","family":"Christen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holdener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.04.001_bib1","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1111\/j.1440-1746.1997.tb00509.x","article-title":"Recent developments in autoimmune liver diseases","volume":"12","author":"Manns","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2006.04.001_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","article-title":"Autoimmune hepatitis","volume":"334","author":"Krawitt","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2006.04.001_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2006.04.001_bib4","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2006.04.001_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2006.04.001_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2006.04.001_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.510280306","article-title":"Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome","volume":"28","author":"Wiesner","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2006.04.001_bib8","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1023\/A:1018836004279","article-title":"Immune phenotype of chronic liver disease","volume":"43","author":"Czaja","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2006.04.001_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2006.04.001_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2008-1040439","article-title":"The asialoglycoprotein receptor as target structure in autoimmune liver diseases","volume":"11","author":"Poralla","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2006.04.001_bib11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2006.04.001_bib12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.04.001_bib13","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2006.04.001_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver\u2013kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.04.001_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/jaut.2001.0565","article-title":"Differences in Anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and-positive Patients","volume":"17","author":"Kitazawa","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2006.04.001_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb08164.x","article-title":"Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis","volume":"84","author":"Lohr","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2006.04.001_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2006.04.001_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0140-6736(90)90070-L","article-title":"Type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"335","author":"Lenzi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2006.04.001_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916930108994106","article-title":"Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C","volume":"33","author":"Miyakawa","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2006.04.001_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.190.2.169","article-title":"Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition","volume":"190","author":"Kammer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2006.04.001_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune disease","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2006.04.001_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/bi00057a013","article-title":"Halothane metabolism: The dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetyl-protein adducts","volume":"32","author":"Christen","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2006.04.001_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1432-1033.1994.tb19082.x","article-title":"Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis: molecular mimicry of CF3CO-lysine by lipoic acid","volume":"223","author":"Christen","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.autrev.2006.04.001_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2006.04.001_bib27","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2006.04.001_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1074-7613(00)80392-1","article-title":"The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD","volume":"7","author":"Delovitch","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2006.04.001_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0171-2985(97)80055-1","article-title":"The appearance of unusual phenotypic cells (CD4+ Mac\u22121+ class II+) in the liver of (NZW\u00d7BXSB)F1 mice is possibly an animal model for autoimmune hepatitis","volume":"197","author":"Amoh","year":"1997","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2006.04.001_bib30","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.152.7.3245","article-title":"Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo","volume":"152","author":"Ando","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1691527","article-title":"Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice","volume":"248","author":"Moriyama","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.autrev.2006.04.001_bib32","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D","article-title":"Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment","volume":"28","author":"Limmer","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib33","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1002\/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E","article-title":"CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes","volume":"32","author":"Sacher","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib34","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.165.5.2415","article-title":"Break of T cell ignorance to a viral antigen in the liver induces hepatitis","volume":"165","author":"Voehringer","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2006.04.001_bib36","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.4049\/jimmunol.169.9.4889","article-title":"DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis","volume":"169","author":"Djilali-Saiah","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2006.04.001_bib37","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2006.04.001_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/A:1021144209209","article-title":"Transgenic animal models for type 1 diabetes: linking a tetracycline-inducible promoter with a virus-inducible mouse model","volume":"11","author":"Christen","year":"2002","journal-title":"Transgenic Res"},{"key":"10.1016\/j.autrev.2006.04.001_bib39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.60.6.1260","article-title":"The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse","volume":"60","author":"Corchero","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.autrev.2006.04.001_bib40","unstructured":"Holdener M, Hintermann A, Rhode A, Wolfe T, Gonzalez FJ, Johnson EF, Manns M, von Herrath MG, Christen U. A novel model for human autoimmune hepatitis: Breaking tolerance to human CYP2D6 by viral infection. (Manuscript) (submitted for publication)."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T10:16:59Z","timestamp":1683454619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1568997206000590"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.04.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}